Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review: Glucose-sensitive insulin
Thomas Høeg-Jensen
Molecular Metabolism (2020) Vol. 46, pp. 101107-101107
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

One hundred years of insulin therapy
Chantal Mathieu, Pieter-Jan Martens, Roman Vangoitsenhoven
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 12, pp. 715-725
Closed Access | Times Cited: 95
‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues
Mark A. Jarosinski, Balamurugan Dhayalan, Nischay Rege, et al.
Diabetologia (2021) Vol. 64, Iss. 5, pp. 1016-1029
Open Access | Times Cited: 89
Current Advances in Stimuli-Responsive Hydrogels as Smart Drug Delivery Carriers
Yulong Zhang, Benjamin M. Wu
Gels (2023) Vol. 9, Iss. 10, pp. 838-838
Open Access | Times Cited: 33
Continuous Glucose Monitoring Enabled by Fluorescent Nanodiamond Boronic Hydrogel
Jian Zhang, Yongjun Zheng, Jimmy Lee, et al.
Advanced Science (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 31
Glucose-sensitive insulin with attenuation of hypoglycaemia
Thomas Høeg-Jensen, Thomas Kruse, Christian L. Brand, et al.
Nature (2024) Vol. 634, Iss. 8035, pp. 944-951
Open Access | Times Cited: 11
The future of insulin therapy
Tim Heise
Diabetes Research and Clinical Practice (2021) Vol. 175, pp. 108820-108820
Open Access | Times Cited: 46
Commemorating insulin's centennial: engineering insulin pharmacology towards physiology
Peter Kurtzhals, Erica Nishimura, Hanne Haahr, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 8, pp. 620-639
Open Access | Times Cited: 34
Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists
Margaret Wu, Ester Carballo‐Jane, Haihong Zhou, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
The developmental history of insulin pharmaceuticals
Hai Qian, Binbin Kou
Elsevier eBooks (2025), pp. 21-39
Closed Access
Catechol-based chemistry for hypoglycemia-responsive delivery of zinc-glucagon via hydrogel-based microneedle patch technology
Amin GhavamiNejad, Jackie Fule Liu, Sako Mirzaie, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
A Century of Progress in Diabetes Care with Insulin: A History of Innovations and Foundation for the Future
Seung‐Hwan Lee, Kun‐Ho Yoon
Diabetes & Metabolism Journal (2021) Vol. 45, Iss. 5, pp. 629-640
Open Access | Times Cited: 32
Regulation and function of insulin and insulin-like growth factor receptor signalling
Eunhee Choi, Cunming Duan, Xiao‐chen Bai
Nature Reviews Molecular Cell Biology (2025)
Closed Access
Diboronate-Modified Hyaluronic Acid for Glucose-Responsive Insulin Delivery
Sijie Xian, Yuanhui Xiang, Katarína Mitrová, et al.
Biomacromolecules (2025)
Closed Access
Structural principles of insulin formulation and analog design: A century of innovation
Mark A. Jarosinski, Balamurugan Dhayalan, Yen‐Shan Chen, et al.
Molecular Metabolism (2021) Vol. 52, pp. 101325-101325
Open Access | Times Cited: 26
Insulin therapy development beyond 100 years
Philip Home, Roopa Mehta
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 10, pp. 695-707
Closed Access | Times Cited: 23
100 Years since the Discovery of Insulin, from Its Discovery to the Insulins of the Future
Carmen Lambert, Elías Delgado
Biomedicines (2024) Vol. 12, Iss. 3, pp. 533-533
Open Access | Times Cited: 2
Engineering an Insulin Complex to Treat Diabetes
William T. Cefalu, Guillermo Arreaza-Rubín
New England Journal of Medicine (2024) Vol. 390, Iss. 23, pp. 2214-2216
Closed Access | Times Cited: 2
Memristor Circuits for Colloidal Robotics: Temporal Access to Memory, Sensing, and Actuation
Jing Yang, Albert Tianxiang Liu, Thomas A. Berrueta, et al.
Advanced Intelligent Systems (2021) Vol. 4, Iss. 4
Open Access | Times Cited: 14
New Horizons: Next-Generation Insulin Analogues: Structural Principles and Clinical Goals
Mark A. Jarosinski, Yen‐Shan Chen, Nicolás Varas, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 4, pp. 909-928
Open Access | Times Cited: 13
Semisynthesis of A6–A11 lactam insulin
Rong Xu, Edwina Jap, Ben Gubbins, et al.
Journal of Peptide Science (2023)
Open Access | Times Cited: 4
Dual-agonist incretin peptides from fish with potential for obesity-related Type 2 diabetes therapy – A review
J. Michael Conlon, Finbarr O’Harte, Peter R. Flatt
Peptides (2021) Vol. 147, pp. 170706-170706
Open Access | Times Cited: 9
Living with Insulin: The story of insulin from people with diabetes
Paolo Di Bartolo, Robert H. Eckel
Diabetes Research and Clinical Practice (2021) Vol. 176, pp. 108857-108857
Closed Access | Times Cited: 8
Celebration of a century of insulin therapy in children with type 1 diabetes
Alan D. Rogol, Lori M. Laffel, Bruce W. Bode, et al.
Archives of Disease in Childhood (2022) Vol. 108, Iss. 1, pp. 3-10
Open Access | Times Cited: 5
Synthetic long-acting insulin analogs for the management of type 1 diabetes: an update
Ulrik Pedersen‐Bjergaard, Therese W. Fabricius, Birger Thorsteinsson
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 16, pp. 2251-2259
Closed Access | Times Cited: 6
In Silico Investigation of the Clinical Translatability of Competitive Clearance Glucose-Responsive Insulins
Jing Yang, Sungyun Yang, Xun Gong, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 10, pp. 1382-1395
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top